Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125506442 | 12550644 | 2 | F | 20160608 | 20160729 | 20160712 | 20160805 | EXP | RO-ABBVIE-16P-135-1670431-00 | ABBVIE | 73.65 | YR | F | Y | 0.00000 | 20160805 | OT | COUNTRY NOT SPECIFIED | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125506442 | 12550644 | 1 | PS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | TWO TABS IN THE MORNING | 1059033 | 206619 | FILM-COATED TABLET | QD | |||||||
| 125506442 | 12550644 | 2 | SS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 1059033 | 206619 | |||||||||||
| 125506442 | 12550644 | 3 | SS | EXVIERA | DASABUVIR | 1 | Oral | ONE TAB IN THE MORNING AND ONE TAB IN THE EVENING | 1060132 | 206619 | FILM-COATED TABLET | BID | |||||||
| 125506442 | 12550644 | 4 | SS | EXVIERA | DASABUVIR | 1 | 1060132 | 206619 | |||||||||||
| 125506442 | 12550644 | 5 | SS | REBETOL | RIBAVIRIN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 125506442 | 12550644 | 6 | SS | REBETOL | RIBAVIRIN | 1 | Y | 0 | |||||||||||
| 125506442 | 12550644 | 7 | C | DICLOFENAC | DICLOFENAC | 1 | 0 | ||||||||||||
| 125506442 | 12550644 | 8 | C | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 0 | |||||||||||
| 125506442 | 12550644 | 9 | C | CONTROLOC | PANTOPRAZOLE SODIUM | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125506442 | 12550644 | 1 | Hepatitis C |
| 125506442 | 12550644 | 2 | Hepatic cirrhosis |
| 125506442 | 12550644 | 3 | Hepatitis C |
| 125506442 | 12550644 | 4 | Hepatic cirrhosis |
| 125506442 | 12550644 | 5 | Hepatitis C |
| 125506442 | 12550644 | 6 | Hepatic cirrhosis |
| 125506442 | 12550644 | 7 | Product used for unknown indication |
| 125506442 | 12550644 | 8 | Hypertension |
| 125506442 | 12550644 | 9 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125506442 | 12550644 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125506442 | 12550644 | Anaemia | |
| 125506442 | 12550644 | Cardiac disorder | |
| 125506442 | 12550644 | Dizziness | |
| 125506442 | 12550644 | Headache | |
| 125506442 | 12550644 | Hyperbilirubinaemia | |
| 125506442 | 12550644 | Hyponatraemia | |
| 125506442 | 12550644 | Insomnia | |
| 125506442 | 12550644 | Nausea | |
| 125506442 | 12550644 | Pericardial effusion | |
| 125506442 | 12550644 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125506442 | 12550644 | 1 | 20160608 | 0 | ||
| 125506442 | 12550644 | 3 | 20160608 | 0 | ||
| 125506442 | 12550644 | 5 | 20160608 | 201607 | 0 | |
| 125506442 | 12550644 | 8 | 2012 | 0 | ||
| 125506442 | 12550644 | 9 | 2012 | 0 |